{
    "Trade/Device Name(s)": [
        "AuditTM MicroCVTM Lipids Linearity Set (Low)",
        "Lipids Linearity"
    ],
    "Submitter Information": "Aalto Scientific, Ltd.",
    "510(k) Number": "K070223",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042318"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "March 13, 2007",
    "Summary Letter Received Date": "January 24, 2007",
    "Submission Date": "January 17, 2007",
    "Regulation Number(s)": [
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Apolipoprotein A1",
        "Apolipoprotein B",
        "Cholesterol",
        "HDL Cholesterol",
        "LDL Cholesterol",
        "Triglyceride"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material",
        "Calibration verification",
        "Proficiency testing material"
    ],
    "Document Summary": "FDA 510(k) summary for AuditTM MicroCVTM Lipids Linearity Set (Low), a five-level lyophilized human serum set for lipid analyte calibration verification and proficiency testing.",
    "Indications for Use Summary": "For verifying analytical measurement range, calibration verification, and proficiency testing of Apolipoprotein A1, Apolipoprotein B, Cholesterol, HDL Cholesterol, LDL Cholesterol, and Triglyceride in laboratory lipids testing methods, using similar reagents and instrumentation per CLIA-88 guidelines.",
    "fda_folder": "Clinical Chemistry"
}